Call
+918447748545

Published on: May 22, 2021
3 minute read
By: Dr Rajan Choudhary

COVID Associated Black Fungus: Succumbing To Black Fungus !

COVID associated Black Fungus: What you need to know

As COVID spreads across India, there has been an increase in reports of associated infection with a black fungus occurring in some patients. It affects the nose, mouth, eyes, and lungs, and can be fatal. This is an infection we need to be educated on, and early recognition of it can be life-saving. Today we will talk about Mucormycosis, the black fungus responsible for these infections, and what you should do to prevent or recognize an infection.

If you want to learn how to recognize the infection, go down to the INFECTION section of the article.

FUNGUS

When our body gets infected by a bacteria or virus, the signs and symptoms are often recognized early because bacteria and viruses are aggressive, with toxins and mechanisms designed to cause harm to our body and cause easily recognizable symptoms. Fungi on the other hand are slow-growing, and usually, our bodies can fight usually fight these infections before they become a problem. We breathe in fungal spores all the time, especially when outside, in the garden, or in fields, and they cause no harm.

Mucormycosis, the responsible fungus, is found in soil, and decaying fruits and vegetables. It can enter our body by inhalation, by eating foods infected with it, or by direct contact with an open wound, thereby entering our blood. It can be found inside the nose of healthy people, causing no problems or disease. Before the COVID pandemic, infection by mucormycosis was up to 80 times more prevalent in India than in other developed countries, though still rare.

IMMUNOSUPPRESSION

Looking at case reports of patients infected with mucormycosis shows a common theme. Immunocompromised patients are at much higher risk of infection by the fungus and are more likely to have severe disease. This includes patients with diabetes, poorly controlled diabetes, patients taking steroids, organ transplant patients (who are usually on immunosuppressive medications to prevent rejection), those with blood cancer (leukemia/lymphoma, reducing your blood immunity).

Diabetes (especially poorly controlled diabetes) is a major problem in these cases, as diabetes is fairly common in India, can lay unrecognized, and if not controlled or treated appropriately the rising blood sugar levels can damage your arteries, nerves, and significantly lower your immunity. Any infection in diabetic patients can be more difficult to treat and spread more quickly, and this is made worse by COVID-19.

COVID causes widespread inflammation throughout the body, especially the lungs, and the resulting damage causes difficulty breathing and death by respiratory failure. Steroids are currently our best way to treat COVID, by suppressing the body’s immune system and preventing lung damage. Unfortunately, this also allows mucormycosis spores inhaled by COVID patients to infect the now vulnerable, damaged airway, lungs, and sinuses, and start spreading. The body’s response to the infection is dampened by the steroids, and in those with diabetes, it is hindered further.

INFECTION

The black fungus usually spreads in the nose and sinuses of the skull, as it prefers a warm, humid environment. From here it can spread into the eyes and in rare cases the brain.

Recognize the symptoms of the fungus, and be very suspicious in patients with diabetes or those who have had high doses of steroids.

- Facial swelling on one side

- Nose or sinus congestion

- Pain in the sinuses, around the nose, and eyes

- Black mold growing around the nose or mouth

- Fever, headache

When it infects the lungs it can cause symptoms such as cough, shortness of breath, or chest pain. Unfortunately, this can be difficult to separate from symptoms of COVID infection.

If you suspect you or someone you know has these symptoms, and they have the risk factors of immunosuppression or diabetes, you should visit a doctor early. Mucormycosis has a high mortality rate, and a delay in diagnosis by even a week can double it. Your doctor will take swab samples from your nose and look for signs of the fungus under a microscope. Blood tests and scans are also helpful in identifying the fungal infection.

TREATMENT AND PREVENTION

Treatment of mucormycosis requires IV antifungals such as Amphotericin B and may involve surgery to remove the infected areas and prevent further spread. This can include surgery in and around the nose, sinuses, and in rare cases even the eyes. This all depends on the extent of the fungal infection.

Prevention is key in these cases. Simple measures such as wearing a mask to reduce inhalation of spores can minimize infection, especially in the vulnerable, though it may not prevent it if they already had spores present in their nose and sinuses. Glucose tests to look for diabetes, and strict control of diabetes will improve your chances significantly. Keeping your blood sugar levels within the normal range is very important, so if you are diabetic now is the time to stick to your diabetic diet and medications.

Finally, we need to be careful when using immunosuppressive medications to treat COVID, and determining which patients should receive steroids (dexamethasone, prednisolone) and other drugs such as tocilizumab. If you are young and healthy, or you have a milder infection of COVID-19, it may be better for you to not take steroids early. Those with more serious COVID-19 infections may need steroids to survive, and in these cases frequent checks for mucormycosis infection is advisable.

The rise in this rare fungal disease in patients with COVID-19 presents a problem, as we do not have much literature to base our recommendations on, the disease is slow-growing and can be difficult to treat. But as always, understanding the disease process for black fungus and knowing its symptoms is important, as is informing your family and friends about this disease.

Read Blog

How Weekly Onsite Yoga Benefits Corporate Wellness: A Preventive Approach to Workplace Health

Corporate wellness programs are evolving rapidly. Traditional initiatives such as annual health checkups and gym memberships are no longer sufficient to address modern workplace health challenges. Rising stress levels, sedentary routines and burnout have pushed organisations to adopt preventive, sustainable wellness strategies. One of the most effective among these is weekly onsite yoga.

Understanding how onsite yoga weekly benefits corporate wellness highlights why this ancient practice has become a modern workplace necessity. Yoga addresses both physical and mental health, making it uniquely suited for today’s high-pressure corporate environments.

Why Corporate Wellness Needs Preventive Solutions

According to the Indian Council of Medical Research (ICMR) and workplace health reports, lifestyle-related disorders such as hypertension, diabetes, obesity and mental health conditions are increasingly affecting working professionals.

Key workplace health challenges include:

prolonged sitting
poor posture
chronic stress
sleep disturbances
reduced physical activity

Preventive interventions are essential to reverse these trends before they result in chronic disease and productivity loss.

What Is Weekly Onsite Yoga?

Weekly onsite yoga involves structured yoga sessions conducted at the workplace by trained instructors. These sessions typically include:

stretching and mobility exercises
breathing techniques
simple yoga postures
relaxation and mindfulness practices

Sessions are designed to be inclusive, requiring no prior yoga experience.

Why Weekly Frequency Matters

Consistency is the foundation of wellness.

Weekly yoga sessions:

reinforce healthy habits
prevent accumulation of stress
support gradual physical improvement
encourage long-term participation

Unlike one-time workshops, weekly programs deliver sustained impact.

Physical Health Benefits of Onsite Yoga

Reduces Musculoskeletal Problems

Desk-based work often leads to back pain, neck stiffness and joint discomfort. Yoga improves:

posture
flexibility
muscle strength

This reduces work-related musculoskeletal disorders.

Improves Cardiovascular and Metabolic Health

Regular yoga practice supports:

blood pressure regulation
improved circulation
better glucose control

WHO recognises yoga and similar mind-body practices as beneficial for lifestyle disease prevention.

Enhances Energy Levels

Yoga improves oxygenation and circulation, reducing fatigue and mid-day energy crashes.

Mental Health Benefits in the Workplace

Reduces Stress and Burnout

Yoga lowers cortisol levels and activates the parasympathetic nervous system, promoting relaxation.

This helps employees:

manage deadlines calmly
recover from mental fatigue
reduce anxiety

Improves Focus and Cognitive Performance

Breathing and mindfulness practices improve:

attention span
mental clarity
decision-making

Better focus directly translates into improved productivity.

Supports Emotional Wellbeing

Regular yoga enhances emotional regulation, reducing irritability and improving workplace relationships.

Impact on Productivity and Performance

Healthy employees perform better.

Weekly onsite yoga contributes to:

reduced absenteeism
fewer stress-related sick days
improved work engagement
sustained productivity

EY-FICCI corporate wellness studies show that preventive wellness programs deliver measurable performance benefits.

Role in Building a Wellness-Oriented Culture

Onsite yoga sends a strong message that employee wellbeing is a priority.

It helps organisations:

foster trust and engagement
encourage work-life balance
create a supportive environment

Wellness culture improves retention and employer branding.

Inclusivity and Accessibility

One of yoga’s biggest strengths is adaptability.

Onsite yoga:

suits all age groups
accommodates different fitness levels
requires minimal equipment
can be modified for health conditions

This inclusivity ensures broad participation.

Cost-Effectiveness and ROI

Compared to advanced medical interventions, onsite yoga is:

low-cost
scalable
preventive rather than reactive

By reducing long-term healthcare costs, yoga delivers high return on investment for employers.

Yoga as Part of Preventive Healthcare

Preventive healthcare focuses on reducing risk factors before disease develops.

Weekly onsite yoga supports prevention by:

lowering stress-related disease risk
improving metabolic health
encouraging active lifestyles
supporting mental resilience

NITI Aayog recognises workplace wellness as a key lever for national health improvement.

Integration with Corporate Wellness Programs

Onsite yoga works best when integrated with:

preventive health checkups
stress management initiatives
nutrition education
digital health tracking

Integrated programs deliver stronger outcomes than isolated activities.

Overcoming Common Barriers

Some organisations hesitate due to:

time constraints
perceived lack of interest
space concerns

However, short, well-structured sessions (30–45 minutes) overcome these challenges effectively.

Long-Term Impact on Organisations

Organisations that adopt weekly onsite yoga observe:

healthier workforce
reduced burnout
improved morale
better long-term healthcare outcomes

Lancet workplace health studies show that consistent mind-body interventions yield benefits within 6–12 months.

Conclusion

Understanding how onsite yoga weekly benefits corporate wellness reveals why it is more than a fitness activity—it is a preventive health strategy. By addressing physical strain, mental stress and lifestyle risks, weekly onsite yoga supports healthier employees, stronger productivity and sustainable wellness culture. In today’s demanding corporate environment, investing in regular yoga sessions is an investment in long-term organisational resilience and success.

References

ICMR – Workplace Health and Lifestyle Disease Reports
National Family Health Survey (NFHS-5) – Adult Health and Stress Indicators
NITI Aayog – Preventive Healthcare and Workplace Wellness Strategy
WHO – Physical Activity, Yoga and Mental Health Guideline
Lancet – Mind-Body Interventions and Workplace Health Outcomes
EY-FICCI – Corporate Wellness and Productivity Report
Statista – Corporate Wellness Program Trends India

Request A Callback

+91

By using this website/app, I confirm that I am at least 18 years old and consent to the processing of my personal data in accordance with the Terms of Service, Privacy Policy, and Declaration.